Home Industries Market Insights About Us Publisher Contact us

2021-2027 Global Antisense and RNAi Therapeutics Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)

ReportID: 551496

|

Published Date: 31/08/2021

|

No. of Pages: 115

|

Categories: Life Sciences

|

Formate :


This report elaborates the market size, market characteristics, and market growth of the Antisense and RNAi Therapeutics industry, and breaks down according to the type, application, and consumption area of Antisense and RNAi Therapeutics. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Antisense and RNAi Therapeutics in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global Antisense and RNAi Therapeutics market covered in Chapter 13:
Marina Biosciences
GSK
Sanofi-Genzyme
Alnylam Pharmaceuticals
Benitec Biopharma

In Chapter 6, on the basis of types, the Antisense and RNAi Therapeutics market from 2015 to 2025 is primarily split into:
RNA Interference
Antisense RNA

In Chapter 7, on the basis of applications, the Antisense and RNAi Therapeutics market from 2015 to 2025 covers:
Oncology
Cardiovascular Diseases (CVDs)
Respiratory Disorders
Renal Diseases
Neurodegenerative Disorders
Genetic Disorders
Infectious Diseases
Other

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content

1 Antisense and RNAi Therapeutics Market - Research Scope
1.1 Study Goals
1.2 Market Definition and Scope
1.3 Key Market Segments
1.4 Study and Forecasting Years

2 Antisense and RNAi Therapeutics Market - Research Methodology
2.1 Methodology
2.2 Research Data Source
2.2.1 Secondary Data
2.2.2 Primary Data
2.2.3 Market Size Estimation
2.2.4 Legal Disclaimer

3 Antisense and RNAi Therapeutics Market Forces
3.1 Global Antisense and RNAi Therapeutics Market Size
3.2 Top Impacting Factors (PESTEL Analysis)
3.2.1 Political Factors
3.2.2 Economic Factors
3.2.3 Social Factors
3.2.4 Technological Factors
3.2.5 Environmental Factors
3.2.6 Legal Factors
3.3 Industry Trend Analysis
3.4 Industry Trends Under COVID-19
3.4.1 Risk Assessment on COVID-19
3.4.2 Assessment of the Overall Impact of COVID-19 on the Industry
3.4.3 Pre COVID-19 and Post COVID-19 Market Scenario
3.5 Industry Risk Assessment

4 Antisense and RNAi Therapeutics Market - By Geography
4.1 Global Antisense and RNAi Therapeutics Market Value and Market Share by Regions
4.1.1 Global Antisense and RNAi Therapeutics Value ($) by Region (2015-2020)
4.1.2 Global Antisense and RNAi Therapeutics Value Market Share by Regions (2015-2020)
4.2 Global Antisense and RNAi Therapeutics Market Production and Market Share by Major Countries
4.2.1 Global Antisense and RNAi Therapeutics Production by Major Countries (2015-2020)
4.2.2 Global Antisense and RNAi Therapeutics Production Market Share by Major Countries (2015-2020)
4.3 Global Antisense and RNAi Therapeutics Market Consumption and Market Share by Regions
4.3.1 Global Antisense and RNAi Therapeutics Consumption by Regions (2015-2020)
4.3.2 Global Antisense and RNAi Therapeutics Consumption Market Share by Regions (2015-2020)

5 Antisense and RNAi Therapeutics Market - By Trade Statistics
5.1 Global Antisense and RNAi Therapeutics Export and Import
5.2 United States Antisense and RNAi Therapeutics Export and Import (2015-2020)
5.3 Europe Antisense and RNAi Therapeutics Export and Import (2015-2020)
5.4 China Antisense and RNAi Therapeutics Export and Import (2015-2020)
5.5 Japan Antisense and RNAi Therapeutics Export and Import (2015-2020)
5.6 India Antisense and RNAi Therapeutics Export and Import (2015-2020)
5.7 ...

6 Antisense and RNAi Therapeutics Market - By Type
6.1 Global Antisense and RNAi Therapeutics Production and Market Share by Types (2015-2020)
6.1.1 Global Antisense and RNAi Therapeutics Production by Types (2015-2020)
6.1.2 Global Antisense and RNAi Therapeutics Production Market Share by Types (2015-2020)
6.2 Global Antisense and RNAi Therapeutics Value and Market Share by Types (2015-2020)
6.2.1 Global Antisense and RNAi Therapeutics Value by Types (2015-2020)
6.2.2 Global Antisense and RNAi Therapeutics Value Market Share by Types (2015-2020)
6.3 Global Antisense and RNAi Therapeutics Production, Price and Growth Rate of RNA Interference (2015-2020)
6.4 Global Antisense and RNAi Therapeutics Production, Price and Growth Rate of Antisense RNA (2015-2020)

7 Antisense and RNAi Therapeutics Market - By Application
7.1 Global Antisense and RNAi Therapeutics Consumption and Market Share by Applications (2015-2020)
7.1.1 Global Antisense and RNAi Therapeutics Consumption by Applications (2015-2020)
7.1.2 Global Antisense and RNAi Therapeutics Consumption Market Share by Applications (2015-2020)
7.2 Global Antisense and RNAi Therapeutics Consumption and Growth Rate of Oncology (2015-2020)
7.3 Global Antisense and RNAi Therapeutics Consumption and Growth Rate of Cardiovascular Diseases (CVDs) (2015-2020)
7.4 Global Antisense and RNAi Therapeutics Consumption and Growth Rate of Respiratory Disorders (2015-2020)
7.5 Global Antisense and RNAi Therapeutics Consumption and Growth Rate of Renal Diseases (2015-2020)
7.6 Global Antisense and RNAi Therapeutics Consumption and Growth Rate of Neurodegenerative Disorders (2015-2020)
7.7 Global Antisense and RNAi Therapeutics Consumption and Growth Rate of Genetic Disorders (2015-2020)
7.8 Global Antisense and RNAi Therapeutics Consumption and Growth Rate of Infectious Diseases (2015-2020)
7.9 Global Antisense and RNAi Therapeutics Consumption and Growth Rate of Other (2015-2020)

8 North America Antisense and RNAi Therapeutics Market
8.1 North America Antisense and RNAi Therapeutics Market Size
8.2 United States Antisense and RNAi Therapeutics Market Size
8.3 Canada Antisense and RNAi Therapeutics Market Size
8.4 Mexico Antisense and RNAi Therapeutics Market Size
8.5 The Influence of COVID-19 on North America Market

9 Europe Antisense and RNAi Therapeutics Market Analysis
9.1 Europe Antisense and RNAi Therapeutics Market Size
9.2 Germany Antisense and RNAi Therapeutics Market Size
9.3 United Kingdom Antisense and RNAi Therapeutics Market Size
9.4 France Antisense and RNAi Therapeutics Market Size
9.5 Italy Antisense and RNAi Therapeutics Market Size
9.6 Spain Antisense and RNAi Therapeutics Market Size
9.7 The Influence of COVID-19 on Europe Market

10 Asia-Pacific Antisense and RNAi Therapeutics Market Analysis
10.1 Asia-Pacific Antisense and RNAi Therapeutics Market Size
10.2 China Antisense and RNAi Therapeutics Market Size
10.3 Japan Antisense and RNAi Therapeutics Market Size
10.4 South Korea Antisense and RNAi Therapeutics Market Size
10.5 Southeast Asia Antisense and RNAi Therapeutics Market Size
10.6 India Antisense and RNAi Therapeutics Market Size
10.7 The Influence of COVID-19 on Asia Pacific Market

11 Middle East and Africa Antisense and RNAi Therapeutics Market Analysis
11.1 Middle East and Africa Antisense and RNAi Therapeutics Market Size
11.2 Saudi Arabia Antisense and RNAi Therapeutics Market Size
11.3 UAE Antisense and RNAi Therapeutics Market Size
11.4 South Africa Antisense and RNAi Therapeutics Market Size
11.5 The Influence of COVID-19 on Middle East and Africa Market

12 South America Antisense and RNAi Therapeutics Market Analysis
12.1 South America Antisense and RNAi Therapeutics Market Size
12.2 Brazil Antisense and RNAi Therapeutics Market Size
12.3 The Influence of COVID-19 on South America Market

13 Company Profiles
13.1 Marina Biosciences
13.1.1 Marina Biosciences Basic Information
13.1.2 Marina Biosciences Product Profiles, Application and Specification
13.1.3 Marina Biosciences Antisense and RNAi Therapeutics Market Performance (2015-2020)
13.2 GSK
13.2.1 GSK Basic Information
13.2.2 GSK Product Profiles, Application and Specification
13.2.3 GSK Antisense and RNAi Therapeutics Market Performance (2015-2020)
13.3 Sanofi-Genzyme
13.3.1 Sanofi-Genzyme Basic Information
13.3.2 Sanofi-Genzyme Product Profiles, Application and Specification
13.3.3 Sanofi-Genzyme Antisense and RNAi Therapeutics Market Performance (2015-2020)
13.4 Alnylam Pharmaceuticals
13.4.1 Alnylam Pharmaceuticals Basic Information
13.4.2 Alnylam Pharmaceuticals Product Profiles, Application and Specification
13.4.3 Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Market Performance (2015-2020)
13.5 Benitec Biopharma
13.5.1 Benitec Biopharma Basic Information
13.5.2 Benitec Biopharma Product Profiles, Application and Specification
13.5.3 Benitec Biopharma Antisense and RNAi Therapeutics Market Performance (2015-2020)

14 Market Forecast - By Regions
14.1 North America Antisense and RNAi Therapeutics Market Forecast (2020-2025)
14.2 Europe Antisense and RNAi Therapeutics Market Forecast (2020-2025)
14.3 Asia-Pacific Antisense and RNAi Therapeutics Market Forecast (2020-2025)
14.4 Middle East and Africa Antisense and RNAi Therapeutics Market Forecast (2020-2025)
14.5 South America Antisense and RNAi Therapeutics Market Forecast (2020-2025)

15 Market Forecast - By Type and Applications
15.1 Global Antisense and RNAi Therapeutics Market Forecast by Types (2020-2025)
15.1.1 Global Antisense and RNAi Therapeutics Market Forecast Production and Market Share by Types (2020-2025)
15.1.2 Global Antisense and RNAi Therapeutics Market Forecast Value and Market Share by Types (2020-2025)
15.2 Global Antisense and RNAi Therapeutics Market Forecast by Applications (2020-2025)

List of Tables and Figures

Figure Antisense and RNAi Therapeutics Picture
Table Antisense and RNAi Therapeutics Key Market Segments
Figure Study and Forecasting Years
Figure Global Antisense and RNAi Therapeutics Market Size and Growth Rate 2015-2025
Figure Industry PESTEL Analysis
Figure Global COVID-19 Status
Figure Market Size Forecast Comparison of Pre COVID-19 and Post COVID-19
Figure Global Antisense and RNAi Therapeutics Value ($) and Growth Rate (2015-2020)
Table Global Antisense and RNAi Therapeutics Value ($) by Countries (2015-2020)
Table Global Antisense and RNAi Therapeutics Value Market Share by Regions (2015-2020)
Figure Global Antisense and RNAi Therapeutics Value Market Share by Regions in 2019
Figure Global Antisense and RNAi Therapeutics Production and Growth Rate (2015-2020)
Table Global Antisense and RNAi Therapeutics Production by Major Countries (2015-2020)
Table Global Antisense and RNAi Therapeutics Production Market Share by Major Countries (2015-2020)
Figure Global Antisense and RNAi Therapeutics Production Market Share by Regions in 2019
Figure Global Antisense and RNAi Therapeutics Consumption and Growth Rate (2015-2020)
Table Global Antisense and RNAi Therapeutics Consumption by Regions (2015-2020)
Table Global Antisense and RNAi Therapeutics Consumption Market Share by Regions (2015-2020)
Figure Global Antisense and RNAi Therapeutics Consumption Market Share by Regions in 2019
Table Global Antisense and RNAi Therapeutics Export Top 3 Country 2019
Table Global Antisense and RNAi Therapeutics Import Top 3 Country 2019
Table United States Antisense and RNAi Therapeutics Export and Import (2015-2020)
Table Europe Antisense and RNAi Therapeutics Export and Import (2015-2020)
Table China Antisense and RNAi Therapeutics Export and Import (2015-2020)
Table Japan Antisense and RNAi Therapeutics Export and Import (2015-2020)
Table India Antisense and RNAi Therapeutics Export and Import (2015-2020)
Table Global Antisense and RNAi Therapeutics Production by Types (2015-2020)
Table Global Antisense and RNAi Therapeutics Production Market Share by Types (2015-2020)
Figure Global Antisense and RNAi Therapeutics Production Share by Type (2015-2020)
Table Global Antisense and RNAi Therapeutics Value by Types (2015-2020)
Table Global Antisense and RNAi Therapeutics Value Market Share by Types (2015-2020)
Figure Global Antisense and RNAi Therapeutics Value Share by Type (2015-2020)
Figure Global RNA Interference Production and Growth Rate (2015-2020)
Figure Global RNA Interference Price (2015-2020)
Figure Global Antisense RNA Production and Growth Rate (2015-2020)
Figure Global Antisense RNA Price (2015-2020)
Table Global Antisense and RNAi Therapeutics Consumption by Applications (2015-2020)
Table Global Antisense and RNAi Therapeutics Consumption Market Share by Applications (2015-2020)
Figure Global Antisense and RNAi Therapeutics Consumption Share by Application (2015-2020)
Figure Global Oncology Consumption and Growth Rate (2015-2020)
Figure Global Cardiovascular Diseases (CVDs) Consumption and Growth Rate (2015-2020)
Figure Global Respiratory Disorders Consumption and Growth Rate (2015-2020)
Figure Global Renal Diseases Consumption and Growth Rate (2015-2020)
Figure Global Neurodegenerative Disorders Consumption and Growth Rate (2015-2020)
Figure Global Genetic Disorders Consumption and Growth Rate (2015-2020)
Figure Global Infectious Diseases Consumption and Growth Rate (2015-2020)
Figure Global Other Consumption and Growth Rate (2015-2020)
Figure North America Antisense and RNAi Therapeutics Market Consumption and Growth Rate (2015-2020)
Table North America Antisense and RNAi Therapeutics Consumption by Countries (2015-2020)
Table North America Antisense and RNAi Therapeutics Consumption Market Share by Countries (2015-2020)
Figure North America Antisense and RNAi Therapeutics Consumption Market Share by Countries (2015-2020)
Figure United States Antisense and RNAi Therapeutics Market Consumption and Growth Rate (2015-2020)
Figure Canada Antisense and RNAi Therapeutics Market Consumption and Growth Rate (2015-2020)
Figure Mexico Antisense and RNAi Therapeutics Market Consumption and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure Europe Antisense and RNAi Therapeutics Market Consumption and Growth Rate (2015-2020)
Table Europe Antisense and RNAi Therapeutics Consumption by Countries (2015-2020)
Table Europe Antisense and RNAi Therapeutics Consumption Market Share by Countries (2015-2020)
Figure Europe Antisense and RNAi Therapeutics Consumption Market Share by Countries (2015-2020)
Figure Germany Antisense and RNAi Therapeutics Market Consumption and Growth Rate (2015-2020)
Figure United Kingdom Antisense and RNAi Therapeutics Market Consumption and Growth Rate (2015-2020)
Figure France Antisense and RNAi Therapeutics Market Consumption and Growth Rate (2015-2020)
Figure Italy Antisense and RNAi Therapeutics Market Consumption and Growth Rate (2015-2020)
Figure Spain Antisense and RNAi Therapeutics Market Consumption and Growth Rate (2015-2020)
Figure Europe COVID-19 Status
Figure Asia-Pacific Antisense and RNAi Therapeutics Market Consumption and Growth Rate (2015-2020)
Table Asia-Pacific Antisense and RNAi Therapeutics Consumption by Countries (2015-2020)
Table Asia-Pacific Antisense and RNAi Therapeutics Consumption Market Share by Countries (2015-2020)
Figure Asia-Pacific Antisense and RNAi Therapeutics Consumption Market Share by Countries (2015-2020)
Figure China Antisense and RNAi Therapeutics Market Consumption and Growth Rate (2015-2020)
Figure Japan Antisense and RNAi Therapeutics Market Consumption and Growth Rate (2015-2020)
Figure South Korea Antisense and RNAi Therapeutics Market Consumption and Growth Rate (2015-2020)
Figure Southeast Asia Antisense and RNAi Therapeutics Market Consumption and Growth Rate (2015-2020)
Figure India Antisense and RNAi Therapeutics Market Consumption and Growth Rate (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Middle East and Africa Antisense and RNAi Therapeutics Market Consumption and Growth Rate (2015-2020)
Table Middle East and Africa Antisense and RNAi Therapeutics Consumption by Countries (2015-2020)
Table Middle East and Africa Antisense and RNAi Therapeutics Consumption Market Share by Countries (2015-2020)
Figure Middle East and Africa Antisense and RNAi Therapeutics Consumption Market Share by Countries (2015-2020)
Figure Saudi Arabia Antisense and RNAi Therapeutics Market Consumption and Growth Rate (2015-2020)
Figure UAE Antisense and RNAi Therapeutics Market Consumption and Growth Rate (2015-2020)
Figure South Africa Antisense and RNAi Therapeutics Market Consumption and Growth Rate (2015-2020)
Figure South America Antisense and RNAi Therapeutics Market Consumption and Growth Rate (2015-2020)
Table South America Antisense and RNAi Therapeutics Consumption by Countries (2015-2020)
Table South America Antisense and RNAi Therapeutics Consumption Market Share by Countries (2015-2020)
Figure South America Antisense and RNAi Therapeutics Consumption Market Share by Countries (2015-2020)
Figure Brazil Antisense and RNAi Therapeutics Market Consumption and Growth Rate (2015-2020)
Table Marina Biosciences Company Profile
Table Marina Biosciences Production, Value, Price, Gross Margin 2015-2020
Figure Marina Biosciences Production and Growth Rate
Figure Marina Biosciences Value ($) Market Share 2015-2020
Table GSK Company Profile
Table GSK Production, Value, Price, Gross Margin 2015-2020
Figure GSK Production and Growth Rate
Figure GSK Value ($) Market Share 2015-2020
Table Sanofi-Genzyme Company Profile
Table Sanofi-Genzyme Production, Value, Price, Gross Margin 2015-2020
Figure Sanofi-Genzyme Production and Growth Rate
Figure Sanofi-Genzyme Value ($) Market Share 2015-2020
Table Alnylam Pharmaceuticals Company Profile
Table Alnylam Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
Figure Alnylam Pharmaceuticals Production and Growth Rate
Figure Alnylam Pharmaceuticals Value ($) Market Share 2015-2020
Table Benitec Biopharma Company Profile
Table Benitec Biopharma Production, Value, Price, Gross Margin 2015-2020
Figure Benitec Biopharma Production and Growth Rate
Figure Benitec Biopharma Value ($) Market Share 2015-2020
Figure North America Market Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Consumption and Growth Rate Forecast (2020-2025)
Figure Asia-Pacific Market Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Consumption and Growth Rate Forecast (2020-2025)
Table Global Antisense and RNAi Therapeutics Market Forecast Production by Types (2020-2025)
Table Global Antisense and RNAi Therapeutics Market Forecast Production Share by Types (2020-2025)
Table Global Antisense and RNAi Therapeutics Market Forecast Value ($) by Types (2020-2025)
Table Global Antisense and RNAi Therapeutics Market Forecast Value Share by Types (2020-2025)
Table Global Antisense and RNAi Therapeutics Market Forecast Consumption by Applications (2020-2025)
Table Global Antisense and RNAi Therapeutics Market Forecast Consumption Share by Applications (2020-2025)

Request For Methodology

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any)

Request For List Of Tables

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any)

Price

Single User

US$3400

Multi User

US$5100

Corporate User

US$5100

Excel Datapack

US$2000

Download Sample Report

Kindly share your specific requirement (if any)
970580f357b66011f3ad9bfd8fd4652a.png

2021-2027 Global Antisense and RNAi Therapeutics Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)